http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#Head http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#provenance http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#pubinfo http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:104798 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_33697 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_1 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.ebi.ac.uk/chebi/searchId.do?chebiId=6494 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.w3.org/2000/01/rdf-schema#label a(CHEBI:lipopolysaccharide) -> r(MGI:Tnf) http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#provenance http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_4 http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/version 1.4 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_3 http://www.w3.org/ns/prov#value Ciliary neurotrophic factor (CNTF) inhibits the production of tumor necrosis factor (TNF) in lipopolysaccharide (LPS)-treated mice and protects against LPS lethality when coadministered with its soluble receptor (sCNTFR alpha). Both of these activities are abolished in adrenalectomized (ADX) mice. LPS-induced pulmonary polymorphonuclear neutrophil (PMN) infiltration and nitric oxide (NO) production were also inhibited by CNTF + sCNTFR alpha but not by CNTF alone. sCNTFR alpha did not alter the clearance or tissue distribution of CNTF. Furthermore, CNTF variants coadministered with sCNTFR alpha protected against LPS toxicity in a manner related to their affinity for the beta components of CNTFR. Thus, inhibition of TNF production and protection against LPS lethality by CNTF/sCNTFR alpha require an intact hypothalamus-pituitary-adrenal axis (HPAA) and may be mediated by endogenous glucocorticoids. This protective effect is, at least in part, due to the inhibition of PMN infiltration and NO production, and appears to be mediated by cells displaying only beta-receptor subtypes. http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/9656141 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/9656141 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#_3 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc#pubinfo http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://purl.org/dc/terms/created 2014-07-03T14:31:00.079+02:00 http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAL8-RQCGNp3xIieaZ5aMY9GeXey6i6XK07UEzezNCIrc http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234